ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1450

Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort

Daniel B. Horton1,2,3, Brian L. Strom1,3, Mary E. Putt3, Carlos D. Rose2, David D. Sherry4 and Julia S. Sammons5, 1Rutgers Biomedical and Health Sciences, New Brunswick, NJ, 2Pediatrics, Nemours A.I. duPont Hospital for Children, Division of Pediatric Rheumatology, Thomas Jefferson University, Wilmington, DE, 3Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Division of Pediatric Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 5Pediatrics, Infection Prevention and Control, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epidemiologic methods, Infection, pediatrics and reactive arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The incidence of Clostridium difficile infection (CDI)
has increased among children, and CDI is associated with significant morbidity
and mortality. Cases of C. difficile infection-associated reactive arthritis (CDIAREA) in
children have been described, but the epidemiology of this complication is
poorly understood.

Methods: We performed a descriptive cohort and
nested case-control study of CDIAREA in individuals aged 2-20 years using the
electronic medical record of two large pediatric care networks from 2004-2013.
Cases of CDIAREA were defined as presence of acute arthritis and/or
tenosynovitis between ²4 weeks before and ³12 weeks after confirmed,
symptomatic CDI with 1) no other apparent cause for arthritis and 2) negative
synovial cultures (if obtained). Each case was compared to up to 4 controls
with CDI without arthritis/tenosynovitis, randomly selected at the time of
CDIAREA diagnosis ±3 months, using conditional logistic regression. Incidence
of CDIAREA was calculated based on cases and unaffected children seen as an
outpatient in the respective care network within the last 2 years. Attack rate
was calculated as cases of CDIAREA per total number of CDIs during the same
time period.

Results: We identified 26 cases of CDIAREA
during the study period, with an incidence of 5.0 cases
per million person-years (95% CI 3.0, 7.8) and an attack rate of 6.4 cases per
1000 CDIs (95% CI 3.6, 10.5). Among cases of CDIAREA, the acute onset of joint
symptoms began a median of 11 days (IQR 7, 15) after gastrointestinal symptom
onset. CDIAREA typically involved multiple joints (median 5, IQR 3, 8) in
migratory fashion (77%), most commonly the hip and knee (Figure). About half of
children with CDIAREA had fever (58%) or rash (54%). Among those with CDIAREA,
5 (19%) were treated for a presumed septic hip arthritis even though all had
negative synovial cultures. All cases with CDIAREA and presumed septic hip
arthritis had post-antibiotic diarrhea and/or other joints affected before
surgical drainage. Not including those with hospital-onset CDI, cases with
CDIAREA were more commonly treated in the emergency room and/or hospitalized
(P=0.02), despite having fewer comorbidities and more community-onset CDI
(Table). Treating providers made a diagnosis of CDIAREA in only 36% of cases
(95% CI 18%, 57%).

Conclusion: CDIAREA is an acute, under-recognized,
potentially morbid reactive arthritis associated with C. difficile infection that is often
confused with septic arthritis. Better recognition of CDIAREA in children is
needed.

Figure. Joint
involvement for children with C. difficile infection-associated reactive arthritis.

CDIAREA joint figure for abstract.001.png

Table. Characteristics of children with C. difficile infection-associated reactive arthritis and controls with C. difficile infection without arthritis

Characteristic

Cases (N=26)

Controls (N=94)

P-valuea

Age, median (IQR)

8 (6, 14)

8 (3, 13)

0.28

Female sex, N (%)

13 (50)

45 (48)

0.75

Race, N (%)

  White

  Black

  Other

19 (73)

3 (12)

4 (15)

68 (72)

18 (19)

8 (9)

0.39b

Number of medical comorbidities, median (IQR)

0 (0, 1)

1 (1, 2)

0.01

Autoimmune comorbidity, N (%)

3 (12)

16 (17)

0.58

Prior C. diff infection, N (%)

1 (4)

10 (11)

0.38

Antibiotic exposure in prior 2 months, N (%)

22 (85)

78 (84)

0.90

Community-onset C. diff infectionc, N (%)

26 (100)

69 (74)

0.004b

Hospitalized, N (%)

  Hospitalized for C. diff symptoms or dehydration

  Hospitalized for arthritis

  Hospitalized for other reason

21 (81)

6 (23)

17 (65)

0

51 (55)

27 (29)

0

24 (36)

0.02

0.77

–

–

Seen in emergency room and/or hospitalized (any reason)

24 (92)

60 (64)

0.02

Seen in emergency room and/or acutely hospitalized for C. diff infection-related illnessd, N (%)

24 (92)

36 (38)

0.001

a P-values were obtained from conditional logistic regression model.

b P-value signifies overall chi-square.

c Symptom onset outside of the hospital or before hospital day 3.

d Hospitalization for abdominal symptoms, dehydration, or arthritis, not including prior hospitalization leading to hospital-associated C. difficile infection.


Disclosure: D. B. Horton, None; B. L. Strom, None; M. E. Putt, None; C. D. Rose, None; D. D. Sherry, None; J. S. Sammons, None.

To cite this abstract in AMA style:

Horton DB, Strom BL, Putt ME, Rose CD, Sherry DD, Sammons JS. Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/clostridium-difficile-infection-associated-reactive-arthritis-in-a-pediatric-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clostridium-difficile-infection-associated-reactive-arthritis-in-a-pediatric-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology